Mystic Asset Management Inc. Makes New Investment in Stryker Corporation $SYK

Key Points

• Mystic Asset Management initiated a Stryker position of 15,922 shares worth approximately $5.0 million, making the medical technology stock 1.1% of its portfolio. Institutional investors collectively own 77.09% of Stryker.
• Analysts maintain a “Moderate Buy” consensus, with an average price target of $386.28 versus a recent share price of $327.97. Stryker recently beat quarterly earnings estimates, reporting $3.69 in EPS and $6.59 billion in revenue.
• Stryker declared a quarterly dividend of $0.88 per share, equivalent to a 1.1% annual yield. However, insiders sold 665,370 shares worth approximately $216.2 million over the past three months.

Mystic Asset Management Inc. bought a new stake in Stryker Corporation (NYSE:SYK - Free Report) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 15,922 shares of the medical technology company's stock, valued at approximately $5,013,000. Stryker makes up 1.1% of Mystic Asset Management Inc.'s investment portfolio, making the stock its 23rd biggest position.

Several other large investors have also modified their holdings of the stock. Gables Capital Management Inc. bought a new stake in Stryker in the second quarter valued at about $25,000. Kilter Group LLC bought a new position in Stryker during the 2nd quarter worth approximately $25,000. Godfrey Financial Associates Inc. acquired a new position in shares of Stryker in the 4th quarter worth approximately $26,000. Sankala Group LLC bought a new stake in shares of Stryker in the 4th quarter valued at approximately $26,000. Finally, United Financial Planning Group LLC bought a new stake in shares of Stryker in the 3rd quarter valued at approximately $27,000. Institutional investors own 77.09% of the company's stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Raymond James Financial set a $370.00 price objective on Stryker in a research note on Friday, July 31st. Evercore set a $350.00 target price on shares of Stryker in a research note on Monday, July 6th. Wolfe Research cut shares of Stryker from an "outperform" rating to a "peer perform" rating in a report on Thursday, August 13th. The Goldman Sachs Group restated a "neutral" rating and issued a $361.00 price target on shares of Stryker in a research report on Friday, May 1st. Finally, Sanford C. Bernstein set a $410.00 price target on shares of Stryker in a report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $386.28.

Stryker Stock Performance

Shares of SYK opened at $327.97 on Friday. The firm has a fifty day moving average of $326.64 and a 200-day moving average of $332.66. The company has a market cap of $125.80 billion, a price-to-earnings ratio of 33.99, a price-to-earnings-growth ratio of 2.17 and a beta of 0.76. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.33 and a current ratio of 2.16. Stryker Corporation has a 1 year low of $281.00 and a 1 year high of $396.86.

Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The medical technology company reported $3.69 earnings per share for the quarter, beating the consensus estimate of $3.49 by $0.20. The firm had revenue of $6.59 billion for the quarter, compared to the consensus estimate of $6.58 billion. Stryker had a net margin of 14.43% and a return on equity of 23.63%. Stryker's quarterly revenue was up 9.4% compared to the same quarter last year. During the same period last year, the firm posted $3.13 EPS. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. As a group, equities analysts anticipate that Stryker Corporation will post 15.02 earnings per share for the current year.

Stryker Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be given a dividend of $0.88 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.52 annualized dividend and a dividend yield of 1.1%. Stryker's payout ratio is currently 36.48%.

Insider Buying and Selling

In other news, insider Debra King sold 826 shares of the stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total value of $277,783.80. Following the completion of the transaction, the insider owned 6,210 shares of the company's stock, valued at approximately $2,088,423. This represents a 11.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Ronda E. Stryker sold 310,000 shares of the firm's stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $312.23, for a total value of $96,791,300.00. Following the transaction, the director directly owned 1,924,880 shares in the company, valued at $601,005,282.40. This trade represents a 13.87% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 665,370 shares of company stock valued at $216,238,501 in the last three months. 4.60% of the stock is currently owned by corporate insiders.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source